|
Jan 17
|
ETF Closures Hit 3-Year High in 2023
|
|
Jan 16
|
Pfizer (PFE) Sees a More Significant Dip Than Broader Market: Some Facts to Know
|
|
Jan 16
|
Pfizer’s Bourla Bets His Pension on Company Stock as CEO Defends Drug Firm
|
|
Jan 15
|
I'm Passing on Pfizer Stock in 2024. Here's Why.
|
|
Jan 14
|
Is Pfizer Stock a Buy in 2024?
|
|
Jan 13
|
7 Incredible Reasons to Buy Pfizer Stock Right Now
|
|
Jan 13
|
2 Red Flags That Could Sink Pfizer in 2024
|
|
Jan 12
|
As diversity, equity and inclusion comes under legal attack, companies quietly alter their programs
|
|
Jan 12
|
Pharma Stock Roundup: MRK to Buy Harpoon, JNJ to Acquire Ambrx Biopharma & More
|
|
Jan 11
|
UPDATE 1-Weight loss drug windfall attracts pharma companies
|
|
Jan 11
|
Drugmakers plot way into obesity market with deals and development
|
|
Jan 11
|
A Bull Market Is Coming: 2 Magnificent Stocks Down More Than 50% to Buy Right Now
|
|
Jan 10
|
Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
|
|
Jan 10
|
Is Pfizer Stock A Sell After Two Years In Free Fall? Or Will Seagen Bolster Sales?
|
|
Jan 10
|
JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market
|
|
Jan 10
|
UPDATE 1-US FDA allows import of syphilis drug to address shortages
|